Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. Lumiera Health Inc.
  6. News
  7. Summary
    NHP   CA5502541066

LUMIERA HEALTH INC.

(NHP)
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Lumiera Health : expands distribution of Bazzzics sleep-aid products nationally

05/21/2021 | 07:29am EDT

MONTREAL - Lumiera Health Inc. (TSXV: NHP) (the 'Company' or 'Lumiera '), a company specializing in the development and commercialization of evidence-based botanical products, is pleased to announce that it has signed an agreement with Vancouver based Ecotrend Ecologics ('Ecotrend') for the national distribution of Bazzzics, a natural health product line made with a proprietary blend of plant-based extracts that have demonstrated efficacy for sleep and anxiety disorders. Founded in 1986 by John Harrison, Ecotrend is a much respected international distributor with over 50 dedicated professionals, representing high quality products and servicing natural health stores and alternative healthcare practitioners across Canada. Lumiera Health CEO Mr. Carlos Ponce states, 'We are very pleased to be working with such an established player in the Natural Health industry. With over 2500 retail and 2500 professional accounts, I look forward to rapidly increasing the number of stores selling Bazzzics so more Canadians will have greater access to better sleep'.

About Lumiera Health Inc.

Lumiera specializes in the development and commercialization of evidence-based botanical products for the healthcare industry. The Company sells both oral and topical botanical agents to help manage unmet medical needs through its Holizen Laboratories division. Lumiera is also developing and commercializing a unique portfolio of products acting on the endocannabinoid system and providing innovative solutions for chronic pain and inflammation. The Company is a pioneer in the health and pain management innovation space and the Lumiera brand is rooted in the core brand values of science, nature and compassion. Passionate about making people feel better, we deliver trustworthy and scientifically proven solutions that work with the body's own system.

Forward-looking information Certain statements contained in this press release constitute 'forward-looking information' as such term is defined in applicable Canadian securities legislation. The words 'may', 'would', 'could', 'should', 'potential', 'will', 'seek', 'intend', 'plan', 'anticipate', 'believe', 'estimate', 'expect' and similar expressions indicate such 'forward-looking information' as they relate to Lumiera. All statements other than statements of historical fact may be forward-looking information. Such statements reflect Lumiera' current views and intentions with respect to future events, and current information available to Lumiera, and are subject to certain risks, uncertainties and assumptions. Such risks and uncertainties include, among others, the risk factors included in Lumiera' annual management's discussion and analysis for the year ended November 30, 2020, which is available under the issuer's SEDAR profile at www.sedar.com. Material factors or assumptions were applied in providing forward-looking information. Many factors could cause the actual results, performance or achievements that may be expressed or implied by such forward-looking information to vary from those described herein should one or more of these risks or uncertainties materialize. Should any factor affect Lumiera in an unexpected manner, or should assumptions underlying the forwardlooking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, Lumiera does not assume responsibility for the accuracy or completeness of such forward-looking information. The forward-looking information included in this press release is made as of the date of this press release and Lumiera undertakes no obligation to publicly update or revise any forward-looking information, other than as required by applicable law.

Contact:

Lumiera Health Inc.

Simon Castonguay

Interim Chief Financial Officer

T: 514-880-7772

E: scastonguay@lumiera.ca

(C) 2021 Electronic News Publishing, source ENP Newswire

All news about LUMIERA HEALTH INC.
09/14LUMIERA HEALTH : announces Private Placement Extension
AQ
08/23LUMIERA HEALTH : begins sales of Awaye pain relief cream on Amazon marketplace
AQ
08/20LUMIERA HEALTH : to Sell Awaye Pain Relief Cream on Amazon Platform
MT
08/20LUMIERA HEALTH : begins sales of Awaye™ pain relief cream on Amazon market..
AQ
08/20Lumiera Health Begins Sales of Awaye Pain Relief Cream on Amazon Marketplace
CI
08/17MARKET CHATTER : BHP Quits Oil, Piles Into Canadian Potash In Overhaul For CEO H..
MT
08/09LUMIERA HEALTH : announces proposed $900,000 Private Placement
AQ
08/06LUMIERA HEALTH : Seeks C$0.9 Million in a Private Placement of Share Units
MT
08/06LUMIERA HEALTH : announces proposed $900,000 Private Placement
AQ
08/06Lumiera Health Inc. announced that it expects to receive CAD 0.9 million in f..
CI
More news
Financials
Sales 2020 0,50 M 0,39 M 0,39 M
Net income 2020 -1,93 M -1,50 M -1,50 M
Net cash 2020 0,99 M 0,77 M 0,77 M
P/E ratio 2020 -1,90x
Yield 2020 -
Capitalization 4,55 M 3,57 M 3,54 M
EV / Sales 2019 18,8x
EV / Sales 2020 8,71x
Nbr of Employees -
Free-Float 68,0%
Chart LUMIERA HEALTH INC.
Duration : Period :
Lumiera Health Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Carlos Ponce Chief Executive Officer
Mario Paradis Chief Financial Officer
Kevin Cole Chairman
Richard Giguere Vice President-Commercial Operations
Sector and Competitors
1st jan.Capi. (M$)
LUMIERA HEALTH INC.-25.00%4
JOHNSON & JOHNSON4.68%433 701
ROCHE HOLDING AG10.97%321 442
PFIZER, INC.19.23%246 078
NOVO NORDISK A/S50.80%232 556
ELI LILLY AND COMPANY36.28%208 604